Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 5/20 | 0.70 |
| ▸ | CDK5 | Q00535 | 2/20 | 0.63 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.63 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.63 |
| ▸ | PIM1 | P11309 | 1/20 | 0.63 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.63 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.63 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.63 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.63 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.55 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.55 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.55 |
| ▸ | LTK | P29376 | 1/20 | 0.54 |
| ▸ | MST1R | Q04912 | 1/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 4/20 | 0.49 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.46 |
| ▸ | PARP11 | Q9NR21 | 3/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29532218 | 1.00 | PARP1 (0.70) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL30775229 | 0.89 | PARP1 (0.57) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL830807 | 0.82 | PARP1 (1.00) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL19608227 | 0.80 | PIK3CD (0.64) | CDK5DYRK1ACLK4PIM1CSNK1A1 | |
| SCHEMBL5076461 | 0.80 | PARP1 (0.81) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL15680317 | 0.78 | ACHE (0.68) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL24148319 | 0.78 | CDK5 (0.61) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL867264 | 0.78 | PARP1 (0.68) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL9475196 | 0.78 | PARP1 (0.68) | PARP1CDK5DYRK1ACLK4PIM1 | |
| SCHEMBL2379452 | 0.78 | CDK5 (0.61) | PARP1CDK5DYRK1ACLK4PIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240025884-A1 | COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | DONG-A ST CO., LTD. (KR) | 2024-01-25 | — | — | US | claimed |
| US-12240836-B2 | Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof | DONG-A ST CO., LTD. (KR) | 2025-03-04 | — | — | US | disclosed |
| US-20240025884-A1 | COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | DONG-A ST CO., LTD. (KR) | 2024-01-25 | — | — | US | disclosed |
| WO-2023165523-A1 | AROMATIC RING-SUBSTITUTED METHOXY DERIVATIVE AND USE THEREOF | 上海璎黎药业有限公司 | 2023-09-07 | — | — | WO | disclosed |
| CN-116693514-A | Aromatic ring substituted methoxy derivative and application thereof | 上海璎黎药业有限公司 | 2023-09-05 | — | — | CN | disclosed |
| EP-3421454-B9 | PIPERIDINE DERIVATIVE | OTSUKA PHARMA CO LTD (JP) | 2023-08-09 | — | — | EP | disclosed |
| EP-3421454-B1 | PIPERIDINE DERIVATIVE | OTSUKA PHARMA CO LTD (JP) | 2023-04-05 | — | — | EP | disclosed |
| CN-108884044-B | Piperidine derivatives | 大塚制药株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-113979995-A | MEK inhibitor and application thereof in medicine | 贝达药业股份有限公司 | 2022-01-28 | — | — | CN | disclosed |
| WO-2021147889-A1 | ISOINDOLINE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 康朴生物医药技术（上海）有限公司 | 2021-07-29 | — | — | WO | disclosed |
| US-20190040039-A1 | PIPERIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-02-07 | — | — | US | disclosed |
| EP-3421454-A1 | PIPERIDINE DERIVATIVE | Otsuka Pharmaceutical Co., Ltd. (JP) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017146246-A1 | PIPERIDINE DERIVATIVE | 大塚製薬株式会社 | 2017-08-31 | — | — | WO | disclosed |
| US-7273861-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2007-09-25 | — | — | US | disclosed |
| US-7273861-B2 | Non-nucleoside reverse transcriptase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2007-09-25 | — | — | US | disclosed |
| US-6903079-B2 | Nucleoside compounds and compositions thereof | INOTEK PHARMACEUTICALS CORPORATION (US) | 2005-06-07 | — | — | US | disclosed |
| US-20030149050-A1 | Inhibitors of inflammation and reperfusion injury and methods of use thereof | INOTEK CORP. | 2003-08-07 | — | — | US | disclosed |
| US-6534651-B2 | Substituted isoindolinone derivatives | INOTEK PHARMACEUTICALS CORP. | 2003-03-18 | — | — | US | disclosed |
| US-20020095044-A1 | Inhibitors of inflammation and reperfusion injury and methods of use thereof | INOTEK PHARMACEUTICALS CORPORATION | 2002-07-18 | — | — | US | disclosed |
| WO-2001077075-A2 | INHIBITORS OF INFLAMMATION AND REPERFUSION INJURY | INOTEK CORPORATION (US) | 2001-10-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020095044-A1 | Inhibitors of inflammation and reperfusion injury and methods of use thereof | IL1B, PTGS1, MMP8 | PARP1 505/4885CDK5 411/4885DYRK1A 3592/4885 |
| US-12240836-B2 | Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof | EIF2AK4, GCN1, GCGR | PARP1 4079/4885CDK5 1211/4885DYRK1A 4802/4885 |
| US-20240025884-A1 | COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | EIF2AK4, GCN1, GCGR | PARP1 4079/4885CDK5 1211/4885DYRK1A 4802/4885 |
| US-20030149050-A1 | Inhibitors of inflammation and reperfusion injury and methods of use thereof | IL1B, PTGS1, MMP8 | PARP1 505/4885CDK5 411/4885DYRK1A 3592/4885 |
| US-20190040039-A1 | PIPERIDINE DERIVATIVE | EP300, SLC11A2, TBC1D5 | PARP1 3419/4885CDK5 1278/4885DYRK1A 4715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.